Peptide Library

Tesamorelin

Tesamorelin

GHRH analog with FDA approval for a specific HIV-related indication; sometimes discussed off-label.

Baseline Labs Generally Required
Provider Evaluation Required

Meet with one of our licensed medical providers to determine whether peptide therapy is appropriate for you. If clinically appropriate, we'll create a personalized treatment plan and coordinate your care through appropriate pharmacy channels in accordance with applicable laws and regulations.

  • Licensed medical provider evaluation
  • Individualized treatment plan
  • Ongoing clinical support
Quick Answer

Tesamorelin is GHRH analog with FDA approval for a specific HIV-related indication; sometimes discussed off-label. Whether it is appropriate depends on your medical history, goals, current medications, and testing — evaluated by a licensed VidaVital Medical provider during a live consultation. Educational content only; not medical advice.

Key Takeaways
  • Tesamorelin is sometimes discussed off-label.
  • Baseline labs are generally required before a provider considers this therapy.
  • Providers may evaluate it in hormone-health, metabolic-health.
  • A licensed VidaVital provider must complete a live consultation before any treatment is prescribed.

What is it?

GHRH analog with FDA approval for a specific HIV-related indication; sometimes discussed off-label. A licensed provider reviews suitability, monitoring, and any needed testing during a live consultation.

What may it support?

  • Body composition
  • Metabolic support

Where might it fit?

advanced pathwayhormone healthmetabolic health

Bloodwork & monitoring

Baseline status
Baseline Labs Generally Required
Common tests
  • CMP
  • CBC
  • Lipid panel
The provider determines follow-up cadence individually.
The provider determines final requirements.

Potential side effects

  • Injection-site reaction
  • Mild GI discomfort
  • Rare allergic reaction

Who may not be a candidate?

  • • Pregnancy
  • • Active malignancy without oncology clearance

Drug interactions

  • • Providers review all medications during consultation

Regulatory disclosures

FDA-approved for HIV-associated lipodystrophy; other uses are off-label.

The medication is FDA-approved for one or more uses, but the use discussed on this page may not be included in its FDA-approved labeling. A licensed provider may consider an off-label use when medically appropriate.

Speak With a Licensed Medical Provider

If you're interested in learning whether Tesamorelin may be appropriate for your health goals, schedule a consultation with a licensed VidaVital Medical provider. Your provider will review your medical history, discuss available treatment options, and determine whether any therapy is clinically appropriate for your individual needs.

A licensed VidaVital Medical provider must complete a live video consultation before determining whether this treatment is medically appropriate.

Frequently asked questions

Do I need bloodwork first?
Your provider decides during your live consultation.
Will VidaVital prescribe this to me?
Only if a licensed provider determines it is medically appropriate after a full evaluation.

Sources

  • Provider-reviewed clinical summary — reviewed 2026-01-15 by VidaVital Medical

Related therapies

Interested in Tesamorelin?

Meet with one of our licensed medical providers to determine whether it's appropriate for you.

If clinically appropriate, we'll create a personalized treatment plan and coordinate your care through appropriate pharmacy channels in accordance with applicable laws and regulations.

  • Personalized evaluation
  • Licensed medical provider review
  • Individualized treatment plan
  • Ongoing clinical support
Request Consultation
The information on this website is for educational purposes and does not constitute medical advice, diagnosis, or a prescription. Treatment eligibility, medication selection, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed medical provider after a live consultation and review of the patient's medical history.